Arthritis Clinical Trials

Links shared publicly online about this topic.

  • 986
    total visits

Arthritis Clinical Trials

clinicalconnection.com

Arthritis Clinical Trials

View full resource at clinicalconnection.com

Tags: Arthritis, Rheumatoid Arthritis, Clinical Trial

  • Share

Most Recently Shared on July 29, 2010 at 11:00 pm By:

RealAge RealAge

Suffer from osteo or rheumatoid arthritis? You may be eligible to participate in a clinical trial: http://bit.ly/apcne1

2 years ago...

NextBio Announces NextBio Clinical, Integrates Patient Genomic Data | Biomarker Commons

biomarkercommons.org — “NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery process to enhance research and development.View full resource at biomarkercommons.org

  • View Related
  • Share

Most Recently Shared on April 23, 2012 at 2:43 pm By:

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS

eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 7:17 am By:

Neurology_OW Neurology OW OW Health

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf

1 week ago...

Revised View Enhances Provenge OS Data

onclive.com — “A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 9:28 pm By:

Oral Bacteria Linked to Arthritic Joint Destruction

painlive.com — “Oral bacteria may be present in the synovial fluid of patients with arthritis and could be a contributing factor to joint failure, according to a pilot study published in the April 2012 issue of the Journal of Clinical Rheumatology.View full resource at painlive.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 7:10 pm By:

HCPLive_Pain HCPLive Pain Management

Oral Bacteria Linked to Arthritic Joint Destruction http://t.co/21KNtr88

1 week ago...

Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's... -- PARIS, April 19, 2012 /PRNewswire/ --

prnewswire.com — “Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease. - Fox Foundation to sponsor a clinical trial to study Sanofi compound -.View full resource at prnewswire.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 1:15 pm By:

sstrumello Scott Strumello Patient Expert

PR: Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's http://t.co/VR1kr3k3 via @PRNewswire

1 week ago...

Vaccine extends life of brain cancer patients - Yahoo! News India

in.news.yahoo.com — “'Vaccine extends life of brain cancer patients' on Yahoo! News India. Washington, April 19 (IANS) A new brain cancer vaccine, which uses material from patients' own tumours, holds promise of extending their lives by several months, show results of a multicentre phase-two clinical trial of the vaccine.View full resource at in.news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 1:05 pm By:

BrainCancer_OW Brain Cancer OW OW Health

Vaccine extends life of brain cancer patients: Washington, April 19 (IANS) A new brain cancer vaccine, which use... http://t.co/Ui9dfsdf

1 week ago...

New Brain Cancer Vaccine Displays Success In Second Clinical Trial - Health News - redOrbit

redorbit.com — “On Tuesday, April 17, researchers from the University of California, San Francisco (UCSF) presented results at the American Association of Neurological Surgeons (AANS) meeting in Miami, Florida that a new brain cancer vaccine tailored to individual subjects had been successful in its second clinical trial.View full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 7:03 pm By:

BrainCancer_OW Brain Cancer OW OW Health

New Brain Cancer Vaccine Displays Success In Second Clinical Trial: Connie K. Ho for http://t.co/nBP7sQqf On Tues... http://t.co/iwLUkdAv

1 week ago...

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 4:01 pm By:

Diabetes_Med News-Medical.Net Health News

Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K

1 week ago...

Drug May Lower Gluten Toxicity in Patients with Celiac Disease - Celiac.com

celiac.com — “Biopharmaceutical development company, BioLineRx, has announced results from pre-clinical trials which show that their compound, BL-7010, an orally available treatment for celiac disease, reduces the ...View full resource at celiac.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 9:19 am By:

csaceliacs csaceliacs Health Organization

Drug May Lower Gluten Toxicity in Patients with Celiac Disease - http://t.co/2y1rcrPk http://t.co/r31MN96a #GF #Celiac

1 week ago...

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis

news-medical.net — “Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 6:26 am By:

NewsMedical News-Medical.Net Health News

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis: Idera Pharmaceuticals, Inc. today announced the t... http://t.co/wEfJcG0T

1 week ago...

Pharmaxis asthma treatment found safe, but is it effective? - Pharmaxis, immunology, Drug Development, clinical trials, Biotechnology, asthma - Australian Life Scientist

lifescientist.com.au — “A phase IIa trial of Pharmaxis’ (ASX:PXS) experimental allergic asthma drug, ASM8, has been shown safe, but more trials will be required to demonstrate efficacy.View full resource at lifescientist.com.au

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 7:08 pm By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Pharmaxis asthma treatment found safe, but is it effective? - http://t.co/afcJp0X8

2 weeks ago...

ASCO University Sign In

asco.org — “ASCO University Sign InView full resource at asco.org

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 7:01 pm By:

ASCO ASCO Medical School

26 yo w/ stage IV melanoma, metast to liver, lungs, skin. Treatment? Download the Focus Under Forty: Melanoma slides http://t.co/VJXzokOI

2 weeks ago...

Shot Delivers Scant Relief for Back Pain (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- Epidural injections provided modest short-term pain relief from lumbrosacral radiculopathy, whether used with steroids or an anti-inflammatory biologic agent, a clinical trial showed.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 5:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Shot Delivers Scant Relief for Back Pain (CME/CE): (MedPage Today) -- Epidural injections provided modest short-te... http://t.co/maY4gt8n

2 weeks ago...

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov

clinicaltrials.gov — “Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.govView full resource at clinicaltrials.gov

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 5:32 pm By:

nataliehodgePersonal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium in '09 and has been named by Brian Dolan of Mobi Heath News as "The First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.

Dr. Hodge's special interests in pediatrics include nutrition, prevention and the potential for the internet to strengthen physician patient relationships. Dr. Hodge is a member of the Health care Information and Management Systems Society (HIMSS), a Fellow of the Academy of Pediatrics' Quality and Innovation Network, and a founding member of the Society for Participatory Medicine. Participatory Medicine is an emerging group of engaged patients and physicians who believe that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Doctor, Pediatrician, Physician, and Active Health Library

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing http://t.co/bhrtpYpP cool hotel room and a cell phone #cure

2 weeks ago...

Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis

medicalnewstoday.com — “According to UCB, certolizumab pegol achieved top-level results in a phase 3 study, which assessed the drug's efficacy and safety in patients with adult-onset active axial spondyloarthrView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 5:05 pm By:

mnt_healthnews MNT Health News Health News

Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis http://t.co/o6piItx0 #healthnews

2 weeks ago...

Advertisement